4th HIV Research for Prevention Conference (HIVR4P // Virtual)

Download All
January 27-28 and February 3-4, 2021
CCO is the official provider of online scientific analysis for HIVR4P 2021 through Capsule Summaries, downloadable slides, rapid expert Webinars, podcasts, and ClinicalThought commentaries.

Capsule Summaries

Slidesets Phase IIb AMP Studies: In Vitro Susceptibility of HIV-1 Isolates to Broadly Neutralizing Antibody VRC01 Predicts HIV Prevention Efficacy in MSM, Transgender Persons, and Cisgender Women
Slidesets Preclinical Study of Biodegradable Implant Releasing TAF for Prevention of Vaginal SHIV Infection in Pigtailed Macaques
Slidesets HPTN 084: Long-Acting Injectable Cabotegravir Superior to Daily Oral TDF/FTC for HIV PrEP in Cisgender Women
Slidesets Islatravir Once Monthly for PrEP Demonstrates Favorable Safety/Tolerability and Meets Pharmacokinetic Threshold Target in Blinded Interim Analysis of Phase IIa Trial
Slidesets CAB LA Detectable in Plasma, Mucosal Tissue/Fluid Following Single IM Injection in Healthy Adults
Slidesets CONRAD 138 (ENRICH): Phase I Trial of Continuous or Interrupted 90-Day TFV/LNG Vaginal Ring in Women Without HIV
Slidesets Low Awareness of and Preference for Event-Driven PrEP Among US MSM
Slidesets PrEP-PP Observational Study: PrEP Initiation Among Pregnant and Postpartum Women in South Africa
Slidesets POWER: Most Diagnosed STIs Asymptomatic Among Adolescent Girls and Young Women Accessing PrEP Services as Part of Integrated Care in Johannesburg, South Africa
Slidesets AMPrEP: Transient Decline in PrEP/Condom Use, Sex With Casual Partners Among MSM During COVID-19 Restrictions in the Netherlands
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Gilead Sciences, Inc.
Janssen Therapeutics, Division of Janssen Products, LP
Merck Sharp & Dohme Corp.
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings